Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Showing latest transactions and SEC Form 4 filings for ETRA.
32 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-11-10 20:14:08 | 2026-11-10 | ETRA | Electra Therapeutics, Inc. | GORDON CARL L | Director, 10% Owner | P - Purchase | $8.08 | +92,116 | 22,284,171 | +0% | +$744,531 |
| M | 2026-11-10 20:09:58 | 2026-11-10 | ETRA | Electra Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director, 10% Owner | P - Purchase | $8.08 | +92,116 | 22,284,171 | +0% | +$744,531 |
| M | 2026-11-05 17:47:52 | 2026-11-05 | ETRA | Electra Therapeutics, Inc. | GORDON CARL L | Director, 10% Owner | P - Purchase | $7.63 | +472,571 | 35,873,607 | +0% | +$3,605,116 |
| M | 2026-11-05 17:39:46 | 2026-11-05 | ETRA | Electra Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director, 10% Owner | P - Purchase | $7.63 | +472,571 | 35,873,607 | +0% | +$3,605,116 |